These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 26159872)

  • 1. Clinical utility of dual-energy contrast-enhanced spectral mammography for breast microcalcifications without associated mass: a preliminary analysis.
    Cheung YC; Tsai HP; Lo YF; Ueng SH; Huang PC; Chen SC
    Eur Radiol; 2016 Apr; 26(4):1082-9. PubMed ID: 26159872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Energy Contrast-Enhanced Spectral Mammography: Enhancement Analysis on BI-RADS 4 Non-Mass Microcalcifications in Screened Women.
    Cheung YC; Juan YH; Lin YC; Lo YF; Tsai HP; Ueng SH; Chen SC
    PLoS One; 2016; 11(9):e0162740. PubMed ID: 27611215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical value of suspicious calcification in the diagnosis and surgical treatment of breast lesions using contrast-enhanced spectral mammography].
    Sun XF; Xing W; Yu SN; Sha YY; Pan L; Chen Q
    Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(1):42-46. PubMed ID: 31914557
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of contrast-enhanced spectral mammography for intramammary cancer staging: preliminary results.
    Blum KS; Rubbert C; Mathys B; Antoch G; Mohrmann S; Obenauer S
    Acad Radiol; 2014 Nov; 21(11):1363-9. PubMed ID: 25127846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions.
    Xing D; Lv Y; Sun B; Xie H; Dong J; Hao C; Chen Q; Chi X
    J Comput Assist Tomogr; 2019; 43(2):245-251. PubMed ID: 30531546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degree of Enhancement on Contrast Enhanced Spectral Mammography (CESM) and Lesion Type on Mammography (MG): Comparison Based on Histological Results.
    Łuczyńska E; Niemiec J; Hendrick E; Heinze S; Jaszczyński J; Jakubowicz J; Sas-Korczyńska B; Rys J
    Med Sci Monit; 2016 Oct; 22():3886-3893. PubMed ID: 27768681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging of breast cancer and the advanced applications of digital mammogram: what the physician needs to know?
    Helal MH; Mansour SM; Zaglol M; Salaleldin LA; Nada OM; Haggag MA
    Br J Radiol; 2017 Mar; 90(1071):20160717. PubMed ID: 28055247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced spectral mammography improves diagnostic accuracy in the symptomatic setting.
    Tennant SL; James JJ; Cornford EJ; Chen Y; Burrell HC; Hamilton LJ; Girio-Fragkoulakis C
    Clin Radiol; 2016 Nov; 71(11):1148-55. PubMed ID: 27296475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesions.
    Travieso-Aja MDM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Vega Benítez V; Pérez-Luzardo O
    Radiol Med; 2019 Oct; 124(10):1006-1017. PubMed ID: 31250270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study.
    Lalji UC; Houben IP; Prevos R; Gommers S; van Goethem M; Vanwetswinkel S; Pijnappel R; Steeman R; Frotscher C; Mok W; Nelemans P; Smidt ML; Beets-Tan RG; Wildberger JE; Lobbes MB
    Eur Radiol; 2016 Dec; 26(12):4371-4379. PubMed ID: 27097789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.
    Fallenberg EM; Schmitzberger FF; Amer H; Ingold-Heppner B; Balleyguier C; Diekmann F; Engelken F; Mann RM; Renz DM; Bick U; Hamm B; Dromain C
    Eur Radiol; 2017 Jul; 27(7):2752-2764. PubMed ID: 27896471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
    Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
    Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the diagnostic value of contrast-enhanced breast MR imaging and mammography on patients with BI-RADS 3-5 microcalcifications.
    Li E; Li J; Song Y; Xue M; Zhou C
    PLoS One; 2014; 9(11):e111217. PubMed ID: 25365327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between quantitative assessment of contrast enhancement in contrast-enhanced spectral mammography (CESM) and histopathology-preliminary results.
    Rudnicki W; Heinze S; Niemiec J; Kojs Z; Sas-Korczynska B; Hendrick E; Luczynska E
    Eur Radiol; 2019 Nov; 29(11):6220-6226. PubMed ID: 31089850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between breast MRI and contrast-enhanced spectral mammography.
    Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
    Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.
    Sorin V; Yagil Y; Yosepovich A; Shalmon A; Gotlieb M; Neiman OH; Sklair-Levy M
    AJR Am J Roentgenol; 2018 Nov; 211(5):W267-W274. PubMed ID: 30240292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the Diagnostic Accuracy of Breast BI-RADS 4 Microcalcification-Only Lesions Using Contrast-Enhanced Mammography.
    Long R; Cao K; Cao M; Li XT; Gao F; Zhang FD; Yu YZ; Sun YS
    Clin Breast Cancer; 2021 Jun; 21(3):256-262.e2. PubMed ID: 33243676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of the enhancement intensity and enhancement pattern of CESM to benign and malignant breast lesions.
    Chi X; Zhang L; Xing D; Gong P; Chen Q; Lv Y
    Medicine (Baltimore); 2020 Sep; 99(37):e22097. PubMed ID: 32925753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.